ALK
ALK, or anaplastic lymphoma kinase: a gene that tells your body how to make proteins that help cells talk to each other.
JUL 01, 2020
2:00 PM SGT
JUL 01, 2020
2:00 PM SGT
Lung cancer management has changed over the last few years with several actionable targets being recognised and mandated in the optimal management of these patients. The biomarker ordering p...
OCT 10, 2019
10:30 AM PDT
OCT 10, 2019
10:30 AM PDT
Accumulation of structural variations (SVs) across the genome is a known trigger factor for oncogenesis. Structural mutations have been clearly implicated in a number of cancers, most notably...
NOV 09, 2017
1:30 PM PST
NOV 09, 2017
1:30 PM PST
The GeneStrat® Genomic Test is a blood-based series of ddPCR tests for DNA (EGFR, KRAS, BRAF) and multiplexed assays for RNA variants (EML4-ALK, ROS1, RET). In this report we will u...
MAY 24, 2017
12:00 PM PDT
MAY 24, 2017
12:00 PM PDT
R&D in life science, material science, and chemistry is burdened by fragmented and unstructured data (“spreadsheet hell”), and ambiguous or unrecorded methodological data. Thi...
SEP 09, 2015
9:00 AM PDT
SEP 09, 2015
9:00 AM PDT
DATE: September 9, 2015TIME: 9:00am PDT, 12:00PM EDTDriver mutations are causally implicated in tumorigenesis and disease progression, and they are defined by molecular abnormalities such as ...
JUN 10, 2015
2:00 PM PDT
JUN 10, 2015
2:00 PM PDT
Matching the mutational profile of a patient's tumor with appropriate targeted agents is a goal of personalized medicine in oncology. The number of FDA-approved targeted therapies, as well as...
SEP 16, 2014
10:00 AM PDT
SEP 16, 2014
10:00 AM PDT
Patients with chromosomal rearrangements resulting in fusion proteins are among the most responsive to published targeted therapy. For example, targeting of the EML4-ALK fusion in non-small c...
